Adjuvant therapy for stage I and II non-small cell lung cancer

被引：1

作者：

Dorr, VJ

Perry, MC

机构：

[1] Div. of Hematology/Medical Oncology, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO 65203

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1997年 / 11卷 / 02期

关键词：

D O I：

10.1016/S0889-8588(05)70430-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Even after curative resection, the overall 5-year survival rate for stage I and II non-small cell lung cancer remains less than optimal. In an attempt to improve survival, adjuvant therapy after curative resection has been evaluated. Chemotherapy, immunotherapy, radiotherapy, and various combinations of these have been investigated as means to improve survival. This article reviews these studies. At this time, adjuvant therapy remains investigational and its use should be limited to clinical trials.

引用

收藏

页码：267 / +

页数：1

相关论文

共 42 条

[1]

BANGMA PJ, 1971, CARCINOMA BRONCHUS M, P163

[2]

BROMLEY LL, 1955, LANCET, V2, P937

[3] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN IN PATIENTS WITH COMPLETELY RESECTED STAGE-I NONSMALL CELL LUNG-CANCER - AN LCSG TRIAL [J].

FELD, R ;

RUBINSTEIN, L ;

THOMAS, PA .

CHEST, 1994, 106 (06) :S307-S309

[4] A PHASE-3 RANDOMIZED TRIAL OF IMMEDIATE COMBINATION CHEMOTHERAPY VS DELAYED COMBINATION CHEMOTHERAPY IN PATIENTS WITH COMPLETELY RESECTED STAGE-II AND STAGE-III NONSMALL CELL-CARCINOMA OF THE LUNG [J].

FIGLIN, RA ;

PIANTODOSI, S .

CHEST, 1994, 106 (06) :S310-S312

[5] 15-YEAR FOLLOW-UP OF ALL PATIENTS IN A STUDY OF POSTOPERATIVE CHEMOTHERAPY FOR BRONCHIAL-CARCINOMA [J].

GIRLING, DJ ;

STOTT, H ;

STEPHENS, RJ ;

FOX, W .

BRITISH JOURNAL OF CANCER, 1985, 52 (06) :867-873

[6] THE IMPACT ON SURVIVAL BY ADJUVANT CHEMOTHERAPY AND RADIATION-THERAPY IN STAGE-II NONSMALL-CELL LUNG-CANCER [J].

GRADISHAR, WJ ;

MICK, R ;

HOFFMAN, PC ;

BITRAN, JD ;

KRISHNASAMY, S ;

FERGUSON, MK ;

GOLOMB, HM .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (05) :405-411

[7] SURGICAL ADJUVANT THERAPY FOR STAGE-II AND STAGE-III ADENOCARCINOMA AND LARGE-CELL UNDIFFERENTIATED CARCINOMA [J].

HOLMES, EC .

CHEST, 1994, 106 (06) :S293-S296

[8] POSTOPERATIVE ADJUVANT CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - PROGNOSTIC VALUE OF DNA PLOIDY AND POSTRECURRENT SURVIVAL [J].

ICHINOSE, Y ;

HARA, N ;

OHTA, M ;

MOTOHIRO, A ;

KUDA, T ;

ASO, H .

JOURNAL OF SURGICAL ONCOLOGY, 1991, 46 (01) :15-20

[9] Clinical highlights from the National Cancer Data Base: 1996 [J].

Jessup, JM ;

McGinnis, LS ;

Winchester, DP ;

Eyre, H ;

Fremgen, A ;

Murphy, GP ;

Menck, HR .

CA-A CANCER JOURNAL FOR CLINICIANS, 1996, 46 (03) :185-&

[10]

KLINGMAN RR, 1990, HEMATOL ONCOL CLIN N, V4, P1079

← 1 2 3 4 5 →